Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Non-Current Debt (2022 - 2023)

Gossamer Bio (GOSS) has 2 years of Non-Current Debt data on record, last reported at $814000.0 in Q4 2023.

  • For Q4 2023, Non-Current Debt fell 93.21% year-over-year to $814000.0; the TTM value through Dec 2023 reached $814000.0, down 93.21%, while the annual FY2023 figure was $814000.0, 93.21% down from the prior year.
  • Non-Current Debt reached $814000.0 in Q4 2023 per GOSS's latest filing, down from $3.6 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $29.2 million in Q1 2022 and bottomed at $814000.0 in Q4 2023.